Functional Foods, Gut Microbiome and Association with Obesity and Metabolic Syndrome: A Literature Review
Source abstract
Abstract
The human gastrointestinal gut consists of about 100 trillion microorganisms, including up to 5000 different types of bacteria, as well as Archaea, Eukarya, parasites, viruses and bacteriophages that together are called the “gut microbiome”. Changes in gut microorganism composition (dysbiosis) can cause various diseases. The present study aims to investigate if diet, and more specifically, functional foods have an impact on the intestinal microbiome, and whether the intestinal microbiome has an influence on metabolic syndrome (MetS) and obesity. This systematic review was accomplished according to PRISMA guidelines, mostly using the key words functional foods, microbiome, obesity, MetS, and Mediterranean diet. The search focused on recent scientific articles from the Pubmed, Scopus, and Google Scholar databases. Most of the studies discussed showed a potential therapeutic effect of the Mediterranean diet, which is rich in beneficial nutrients, on body weight and fat deposition, through reshaping of the gut microbiome’s synthesis. This literature review showed a possible relationship between microflora metabolites, endotoxemia, obesity and MetS. The role of probiotics, prebiotics, and polyphenols in the prevention of obesity and MetS is of high importance in promoting healthy aging. The future challenge is to comprehend how different dietary patterns could regulate the gut microflora’s composition and whether these changes could be long term.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Diet and metabolism studies · Gut microbiota and health · Nutritional Studies and Diet
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Unit of Human Nutrition, Laboratory of Nutrition and Public Health, Department of Food Science and Nutrition, University of the Aegean, Leoforos Dimokratias 66, 81400 Myrina, Greece
Laboratory of Hematology, University General Hospital of Ioannina, Stavrou Niarchou Avenue, 45500 Ioannina, Greece
References (77)
Show source-provided references
1. Influence of gut microbiome on the human physiology10.1007/s43393-021-00052-w ↗
2. Croci, S., D’Apolito, L.I., Gasperi, V., Catani, M.V., and Savini, I. (2021). Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients, 13.10.3390/nu13051389 ↗
3. Gut microbiome and metabolic syndrome10.1016/j.dsx.2016.01.024 ↗
4. Beam, A., Clinger, E., and Hao, L. (2021). Effect of Diet and Dietary Components on the Composition of the Gut Microbiota. Nutrients, 13.10.3390/nu13082795 ↗
5. Montero, C.G., Martínez, O.F., Gómez-Lahoz, A.M., Pekarek, L., Castellanos, A.J., Noguerales-Fraguas, F., Coca, S., Guijarro, L., García-Honduvilla, N., and Asúnsolo, A. (2021). Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota–Immune System Interplay. Implications for Health and Disease. Nutrients, 13.10.3390/nu13020699 ↗
6. The Human Microbiota in Health and Disease10.1016/J.ENG.2017.01.008 ↗
7. The Impact of Diet and Lifestyle on Gut Microbiota and Human Health10.3390/nu7010017 ↗
8. Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.10.3390/nu12051474 ↗
9. An overview of the complex interaction between obesity and target organ dysfunction: Focus on redox-inflammatory state10.1186/s41110-023-00206-x ↗
10. Cerdó, T., García-Santos, J.A., Bermúdez, M.G., and Campoy, C. (2019). The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients, 11.10.3390/nu11030635 ↗
11. Interactions of gut microbiota with functional food components and nutraceuticals10.1016/j.phrs.2009.11.001 ↗
12. Dietary Polyphenols and Obesity: A Review of Polyphenol Effects on Lipid and Glucose Metabolism, Mitochondrial Homeostasis, and Starch Digestibility and Absorption10.1007/s11130-022-01034-6 ↗
13. Food-derived regulatory factors against obesity and metabolic syndrome10.1080/09168451.2017.1401912 ↗
14. Li, H.Y., Zhou, D.D., Gan, R.Y., Huang, S.Y., Zhao, C.N., Shang, A., Xiao-Yu Xu, X.Y., and Li, H.B. (2021). Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13.10.3390/nu13093211 ↗
15. Prebiotics in the management of components of the metabolic syndrome10.1016/j.maturitas.2017.07.005 ↗
16. Green, M., Arora, K., and Prakash, S. (2020). Microbial Medicine: Prebiotic Probiotic Functional Foods to Target Obesity Metabolic Syndrome. Int. J. Mol. Sci., 21.10.3390/ijms21082890 ↗
17. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases10.5507/bp.2016.052 ↗
18. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era
19. Gut microbiota and metabolic syndrome10.1097/CM9.0000000000000696 ↗
20. The Influence of the Western Diet on Microbiota and Gastrointestinal Immunity10.1146/annurev-food-052720-011032 ↗
21. Obesity and the gut microbiome: Striving for causality10.1016/j.molmet.2012.07.002 ↗
22. Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods10.1111/1541-4337.12565 ↗
23. Luisi, M., Lucarini, L., Biffi, B., Rafanelli, E., Pietramellara, G., Durante, M., Vidali, S., Provensi, G., Madiai, S., and Francesca Gheri, C. (2019). Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects. Front. Pharmacol., 10.10.3389/fphar.2019.01366 ↗
24. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake10.1136/gutjnl-2019-320438 ↗
25. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide10.1073/pnas.1904099116 ↗
26. Colonic butyrate- producing communities in humans: An overview using omics data10.1128/mSystems.00130-17 ↗
27. Ismael, S., Marta, P., Silvestre, M., Vasques, M., Araújo, J., Morais, J., Duarte, M.I., Pestana, D., Faria, A., and Pereira-Leal, J. (2021). A Pilot Study on the Metabolic Impact of Mediterranean Diet in Type 2 Diabetes: Is Gut Microbiota the Key?. Nutrients, 13.10.3390/nu13041228 ↗
28. Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition10.1093/nutrit/nuz015 ↗
29. Recent advances with alkaline phosphatase isoenzymes and their inhibitors10.1002/ardp.202000011 ↗
30. Mediterranean diet and faecal microbiota: A transversal study10.1039/C6FO00105J ↗
31. A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects10.1002/edm2.402 ↗
32. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients—A randomized double-blind placebo-controlled pilot study10.1186/1475-2891-12-138 ↗
33. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome10.1016/j.nut.2015.11.001 ↗
34. Effects of probiotic yogurt on glycemic indexes and endothelial dysfunction markers in patients with metabolic syndrome10.1016/j.nut.2018.12.011 ↗
35. Inflammatory bio-markers and cardiovascular risk prediction10.1046/j.1365-2796.2002.01019.x ↗
36. Szuli’nska, M., Łoniewski, I., van Hemert, S., Sobieska, M., and Bogda’nski, P. (2018). Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial. Nutrients, 10.10.3390/nu10060773 ↗
37. Oligofructose Decreases Serum Lipopolysaccharide and Plasminogen Activator Inhibitor-1 in Adults with Overweight/Obesity10.1002/oby.21763 ↗
38. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized-controlled clinical trial10.3109/09637486.2013.836738 ↗
39. Correction to: Prebiotic efect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: A randomised controlled trial10.1007/s00394-020-02314-0 ↗
40. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity10.1053/j.gastro.2017.05.055 ↗
41. Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial10.1002/ptr.4715 ↗
42. A water-soluble tomato extract rich in secondary plant metabolites lowers trimethylamine-n-oxide and modulates gut microbiota: A randomized, double-blind, placebo-controlled cross-over study in overweight and obese adults10.1016/j.tjnut.2022.11.009 ↗
43. The effects of trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial
44. Korsholm, A.S., Nordstrøm Kjær, T., Ornstrup, M.J., and Bønløkke Pedersen, S. (2017). Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment. Int. J. Mol. Sci., 18.10.3390/ijms18030554 ↗
45. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation A randomized controlled trial10.1007/s00394-004-0452-8 ↗
46. Extra virgin olive oil high in polyphenols improves antioxidant status in adults: A double-blind, randomized, controlled, cross-over study (OLIVAUS)10.1007/s00394-021-02712-y ↗
47. Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight10.1007/s13668-019-00281-5 ↗
48. Role of prebiotics in regulation of microbiota and prevention of obesity10.1016/j.foodres.2018.07.013 ↗
49. The role of diet and intestinal microbiota in the development of metabolic syndrome10.1016/j.jnutbio.2019.03.017 ↗
50. Malesza, I.J., Malesza, M., Walkowiak, J., Mussin, N., Dariusz Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J., and Madry, E. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells, 10.10.3390/cells10113164 ↗
51. Campaniello, D., Corbo, M.R., Sinigaglia, M., Speranza, B., Racioppo, A., Altieri, C., and Bevilacqua, A. (2022). How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives. Nutrients, 14.10.3390/nu14122456 ↗
52. Human gut microbiota/microbiome in health and diseases10.1007/s10482-020-01474-7 ↗
53. Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases
54. Polyphenols and their anti-obesity role mediated by the gut microbiota: A comprehensive review10.1007/s11154-020-09622-0 ↗
55. Gorzynik-Debicka, M., Przychodzen, P., Cappello, F., Kuban-Jankowska, A., Marino Gammazza, A., Knap, N., Wozniak, M., and Gorska-Ponikowska, M. (2018). Potential Health Benefits of Olive Oil Plant Polyphenols. Int. J. Mol. Sci., 19.10.3390/ijms19030686 ↗
56. Nani, A., Murtaza, B., Sayed Khan, A., Akhtar Khan, N., and Hichami, A. (2021). Antioxidant and Anti- Inflammatory Potential of Polyphenols Contained in Mediterranean Diet in Obesity: Molecular Mechanisms. Molecules, 26.10.3390/molecules26040985 ↗
57. Rigacci, S., and Stefani, M. (2016). Nutraceutical Properties of Olive Oil Polyphenols An Itinerary from Cultured Cells through Animal Models to Humans. Int. J. Mol. Sci., 17.10.3390/ijms17060843 ↗
58. Boccellino, M., and D’Angelo, S. (2020). Anti-Obesity Effects of Polyphenol Intake: Current Status Future Possibilities. Int. J. Mol. Sci., 21.10.3390/ijms21165642 ↗
59. Healthy dietary patterns to reduce obesity-related metabolic disease: Polyphenol-microbiome interactions unifying health effects across geography10.1097/MCO.0000000000000697 ↗
60. The role of a Mediterranean diet and physical activity in decreasing age-related inflammation through modulation of the gut microbiota composition10.1017/S0007114521003251 ↗
61. Deledda, A., Annunziata, G., Tenore, G.C., Palmas, V., Manzin, A., and Velluzzi, F. (2021). Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation. Antioxidants, 10.10.3390/antiox10050708 ↗
62. Polyphenols: A concise overview on the chemistry, occurrence, and human health10.1002/ptr.6419 ↗
63. Chaplin, A., Carpéné, C., and Mercader, J. (2018). Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients, 10.10.3390/nu10111651 ↗
64. Mediterranean products as promising source of multi- target agents in the treatment of metabolic syndrome10.1016/j.ejmech.2019.111903 ↗
65. Saibandith, B., Spencer, J.P.E., Rowland, I.R., and Commane, D.M. (2017). Olive Polyphenols and the Metabolic Syndrome. Molecules, 22.10.3390/molecules22071082 ↗
66. Peyrol, J., Riva, C., and Amiot, M.J. (2017). Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders. Nutrients, 9.10.3390/nu9030306 ↗
67. Probiotics for human use10.1111/nbu.12334 ↗
68. The gut microbiota–brain axis: Role of the gut microbial metabolites of dietary food in obesity10.1016/j.foodres.2022.110971 ↗
69. Hills, R., Benjamin, A., Pontefract, B., Hillary, R., Mishcon, H., and Cody, A. (2019). Black C, Sutton S, Theberge C, Gut Microbiome: Profound Implications for Diet and Disease. Nutrients, 11.10.3390/nu11071613 ↗
70. An insight into gut microbiota and its functionalities10.1007/s00018-018-2943-4 ↗
71. Influence of the microbiota and probiotics in obesity
72. Leeming, E., Johnson, A., Spector, T., and Le Roy, C. (2019). Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients, 11.10.3390/nu11122862 ↗
73. Merra, G., Noce, A., Marrone, G., Cintoni, M., Tarsitano, M.G., Capacci, A., and De Lorenzo, A. (2021). Influence of Mediterranean Diet on Human Gut Microbiota. Nutrients, 13.10.3390/nu13010007 ↗
74. Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., and Izzo, A. (2019). Gut Microbiota and Obesity: A Role for Probiotics. Nutrients, 11.10.3390/nu11112690 ↗
75. The gut microbiota and host health: A new clinical frontier10.1136/gutjnl-2015-309990 ↗
76. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome10.1136/gutjnl-2015-309957 ↗
77. Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population10.1017/S0007114517001593 ↗